Lv1
36 积分 2024-08-15 加入
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
1天前
已完结
Development of [225Ac]Ac‑LNC1011 for targeted alpha-radionuclide therapy of prostate cancer
3天前
已完结
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy
1个月前
已完结
FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy
1个月前
已完结
Synthesis, Labeling and Preclinical Evaluation of a Squaric Acid Containing PSMA Inhibitor Labeled with 68 Ga: A Comparison with PSMA-11 and PSMA-617
5个月前
已完结
Byproducts in the synthesis of [68Ga]Ga-PSMA-11
5个月前
已完结
Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells
6个月前
已完结
Characterization of single neurons reprogrammed by pancreatic cancer
8个月前
已完结
Targeting metabolic circuitry to supercharge CD8 T cell antitumor responses +
8个月前
已完结
177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers
9个月前
已完结
皖公网安备34019202002308
